Stockscreener 앱 받기
1.9648
0.52%
-0.0102
시장 영업 전:
1.88
-0.0848
-4.32%
전일 마감가:
$1.975
열려 있는:
$1.91
하루 거래량:
21,439
Relative Volume:
0.50
시가총액:
$19.99M
수익:
-
순이익/손실:
$-17.93M
주가수익비율:
-1.1101
EPS:
-1.77
순현금흐름:
$-14.28M
1주 성능:
-1.27%
1개월 성능:
-12.68%
6개월 성능:
-16.39%
1년 성능:
+21.28%
1일 변동 폭
$1.88
$2.0983
1주일 범위
$1.88
$2.1749
52주 변동 폭
$1.325
$3.26
Cocrystal Pharma Inc Stock (COCP) Company Profile
명칭
Cocrystal Pharma Inc
전화
(786) 459-1831
주소
19805 N. CREEK PARKWAY, BOTHELL, WA
COCP을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
COCP
Cocrystal Pharma Inc
|
1.9648 | 19.99M | 0 | -17.93M | -14.28M | -1.77 |
|
VRTX
Vertex Pharmaceuticals Inc
|
427.89 | 110.19B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
687.80 | 75.58B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
647.39 | 38.71B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
264.99 | 34.18B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
117.25 | 28.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Cocrystal Pharma Inc Stock (COCP) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2020-07-08 | 개시 | H.C. Wainwright | Buy |
Cocrystal Pharma Inc 주식(COCP)의 최신 뉴스
Influenza Pipeline Insights, Clinical Trials Analysis, Emerging Therapies and Companies | DelveInsight - EIN News
**Cocrystal Pharma, Inc. Presents Corporate Update to Investment Community** - Defense World
Midday Market Movers: Biggest Stock Declines of the Day – Market - HPBL
Cocrystal Pharma Engages Investors with Limited Disclosure - TipRanks
Cocrystal Pharma Reports Positive Phase 1 Results with Oral Pan-Viral Protease Inhibitor CDI-988 for Norovirus and Coronavirus Infections - Defense World
Cocrystal Pharma Extends Phase 2a Influenza Drug Study Amid Lower Infection Rates, Stock Near 52-Week High - HPBL
COCP: Phase 2a Trial of CC-42344 Extended - Smartkarma
COCP: Phase 2a Trial of CC-42344 Extended… - Zacks Small Cap Research
Cocrystal Pharma Reports Positive Phase 1 Study Results - TipRanks
Cocrystal Pharma Reports Phase 1 Results with Oral, - GlobeNewswire
Cocrystal Pharma Reports Phase 1 Results with Oral, Broad-Acting Antiviral Drug CDI-988 for Prophylaxis and Treatment of Norovirus, Coronaviruses and Other Viral Infections - Yahoo Finance
Nuveen New York Quality Municipal Income Fund Announces Key Board ChangesOn December 31, 2024, Nuveen New York Quality Municipal Income Fund (NYSE:NAN) submitted a Form 8-K filing with the Securities and Exchange Commission detailing not - Defense World
CLS Holdings USA, Inc. Executes Agreement to Amend Convertible Debentures - Defense World
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Sees Large Growth in Short Interest - Defense World
BRC Inc. (NYSE: BRCC) Amends Credit Agreements and Enters into $40 Million Term Loan Facility - Defense World
Eyenovia (NASDAQ:EYEN) Enters into Amended and Restated Sales Agreement with Chardan Capital Markets, LLC - Defense World
Supermarket Income REIT (OTCMKTS:SUPIF) Shares Up 0.7% – Should You Buy? - Defense World
Cornish Metals (LON:CUSN) Shares Up 1.1% – What’s Next? - Defense World
Greenwave Technology Solutions (NASDAQ:GWAV) Stock Price Down 3.9% – Here’s What Happened - Defense World
Cocrystal Pharma, Inc. to Extend Phase 2a Influenza Challenge Study with Oral PB2 Inhibitor CC-42344 - Marketscreener.com
Dow Dips Over 100 Points; Cocrystal Pharma Shares Slide - Benzinga
Cocrystal Pharma Shares Drop 35% Following Phase 2a Study Extens - GuruFocus.com
Cocrystal Pharma Shares Drop 35% Following Phase 2a Study Extension Announcement - GuruFocus.com
Stock market news: Coeptis Therapeutics Holdings -96.03%, OptiNose -93.07% among biggest losers during mid day trading - Business Upturn
Cocrystal stock plunges 40% on influenza drug update - MSN
Crude Oil Rises 1%; Sangamo Therapeutics Shares Plummet - Benzinga
Cocrystal stock plunges 40% on influenza drug update (COCP:NASDAQ) - Seeking Alpha
US Stocks Open Higher; House Prices Increase In October - Benzinga
Equitable Holdings, Inc. (NYSE: EQH): Insider Trades, Institutional Moves, and Market Momentum - HPBL
Alexander, Inc. (NYSE: ALX): A Deep Dive into Rising Short Interest, Dividends, and Institutional Activity - HPBL
EQT Corporation: A Deep Dive into the Natural Gas Giant Performance and Market Insights – News - HPBL
Cocrystal Pharma Extends Enrollment for Influenza Study - TipRanks
Cocrystal Pharma Shares Fall After Flu-Treatment Study Is Extended - MarketWatch
Carter, Inc. Faces Growing Short Interest and Market Dynamics in December 2024 – News - HPBL
Canoo Downgraded by Stifel Amid Rising Liquidity Risks and Operational Challenges – News - HPBL
Wall Street holiday: When are Nasdaq, NYSE shut for trading on account of New year’s holiday- December 31 or January 1? | Stock Market News - Mint
Cocrystal Pharma extends trial due to low flu infection rate - Investing.com
Stock Market Movers Today • Top Gainers & Losers - Benzinga
Cocrystal Pharma to Extend Phase 2a Influenza Challenge Study with Oral PB2 inhibitor CC-42344 - GlobeNewswire
Cocrystal Pharma Extends Phase 2a Flu Drug Trial Despite Strong Safety Profile, Low Infection Rates Challenge Study - StockTitan
Short Interest in Cocrystal Pharma, Inc. (NASDAQ:COCP) Increases By 150.0% - Defense World
Falcon’s Beyond Global, Inc. (NASDAQ:FBYD) Short Interest Up 157.7% in December - Defense World
Astellas Pharma Inc. (OTCMKTS:ALPMY) Short Interest Up 150.7% in December - Defense World
COCP stock touches 52-week high at $3.1 amid market optimism - Investing.com Canada
Athira Pharma (NASDAQ:ATHA) Stock Quotes, Forecast and News Summary - Benzinga
Fmr LLC Buys 2,445 Shares of Kearny Financial Corp. (NASDAQ:KRNY) - Defense World
Prada (OTCMKTS:PRDSF) Share Price Crosses Above Two Hundred Day Moving Average – Should You Sell? - Defense World
MetLife (NYSE:MET) Downgraded by StockNews.com to Hold - Defense World
US Penny Stocks To Watch In December 2024 - Yahoo Finance
Detection of Hydrogen Atoms Using Only 3D ED/MicroED and Contribution to Structure Determining Salts or Cocrystals - ACS Publications
Robert W. Baird Boosts Bloom Energy (NYSE:BE) Price Target to $32.00 - Defense World
Cocrystal Pharma Inc (COCP) 재무 분석
매출
순이익
현금흐름
주당 순 이익
4.81%
자본화:
|
볼륨(24시간):